jin-a02
Small moleculeexperimental
Clinical trial activity
1 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 31, 2022 (NCT05394831)
Timeline
No events for the selected filters.
Indications
Mechanism of action
- Epidermal growth factor receptor erbB1ANTAGONIST
EGFR antagonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05394831 | Phase 1/Phase 2 (Phase 2) | Dec 31, 2022 | — |
Showing 1 of 1 trials
Page 1 / 1